Brooks DA - Search Results

1

Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease.

Fuller M, Lovejoy M, Brooks DA, Harkin ML, Hopwood JJ, Meikle PJ. Fuller M, et al. Among authors: brooks da. Clin Chem. 2004 Nov;50(11):1979-85. doi: 10.1373/clinchem.2004.037937. Epub 2004 Sep 13. Clin Chem. 2004. PMID: 15364892

2

Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots.

Hein LK, Meikle PJ, Dean CJ, Bockmann MR, Auclair D, Hopwood JJ, Brooks DA. Hein LK, et al. Among authors: brooks da. Clin Chim Acta. 2005 Mar;353(1-2):67-74. doi: 10.1016/j.cccn.2004.10.009. Clin Chim Acta. 2005. PMID: 15698592

3

Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples.

Dean CJ, Bockmann MR, Hopwood JJ, Brooks DA, Meikle PJ. Dean CJ, et al. Among authors: brooks da. Clin Chem. 2006 Apr;52(4):643-9. doi: 10.1373/clinchem.2005.061838. Epub 2006 Feb 23. Clin Chem. 2006. PMID: 16497940 Free article.

4

Immunochemistry of lysosomal storage disorders.

Parkinson-Lawrence E, Fuller M, Hopwood JJ, Meikle PJ, Brooks DA. Parkinson-Lawrence E, et al. Among authors: brooks da. Clin Chem. 2006 Sep;52(9):1660-8. doi: 10.1373/clinchem.2005.064915. Epub 2006 Jul 13. Clin Chem. 2006. PMID: 16840586 Review.

5

N-acetylgalactosamine-6-sulfatase protein detection in MPS IVA patient and unaffected control samples.

Parkinson-Lawrence EJ, Muller VJ, Hopwood JJ, Brooks DA. Parkinson-Lawrence EJ, et al. Among authors: brooks da. Clin Chim Acta. 2007 Feb;377(1-2):88-91. doi: 10.1016/j.cca.2006.08.030. Epub 2006 Sep 1. Clin Chim Acta. 2007. PMID: 17027703

6

Absence of α-galactosidase cross-correction in Fabry heterozygote cultured skin fibroblasts.

Fuller M, Mellett N, Hein LK, Brooks DA, Meikle PJ. Fuller M, et al. Among authors: brooks da. Mol Genet Metab. 2015 Feb;114(2):268-73. doi: 10.1016/j.ymgme.2014.11.005. Epub 2014 Nov 12. Mol Genet Metab. 2015. PMID: 25468650

7

Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker.

Meikle PJ, Brooks DA, Ravenscroft EM, Yan M, Williams RE, Jaunzems AE, Chataway TK, Karageorgos LE, Davey RC, Boulter CD, Carlsson SR, Hopwood JJ. Meikle PJ, et al. Among authors: brooks da. Clin Chem. 1997 Aug;43(8 Pt 1):1325-35. Clin Chem. 1997. PMID: 9267309

8

Immune response to enzyme replacement therapy: single epitope control of antigen distribution from circulation.

Glaros EN, Turner CT, Parkinson EJ, Hopwood JJ, Brooks DA. Glaros EN, et al. Among authors: brooks da. Mol Genet Metab. 2002 Sep-Oct;77(1-2):127-35. doi: 10.1016/s1096-7192(02)00148-8. Mol Genet Metab. 2002. PMID: 12359140

9

Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I.

Kakavanos R, Turner CT, Hopwood JJ, Kakkis ED, Brooks DA. Kakavanos R, et al. Among authors: brooks da. Lancet. 2003 May 10;361(9369):1608-13. doi: 10.1016/S0140-6736(03)13311-9. Lancet. 2003. PMID: 12747881 Review.

10

Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder.

Brooks DA, Kakavanos R, Hopwood JJ. Brooks DA, et al. Trends Mol Med. 2003 Oct;9(10):450-3. doi: 10.1016/j.molmed.2003.08.004. Trends Mol Med. 2003. PMID: 14557058 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters